Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine1A receptor-mediated feedback: A microdialysis study in the amygdala

Journal of Neurochemistry

Volumn 76, Issue 6, 2001, Pages 1645-1653

  Bosker, F J ^a   Cremers, T I F H ^b   Jongsma, M E ^b   Westerink, B H C ^b   Wikstrom H V ^b   Den Boer, J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

5 HT1A receptor; Amygdala; Augmentation; Citalopram; Desensitization; Feedback

Indexed keywords

CITALOPRAM; FLESINOXAN; SEROTONIN 1A RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; FEEDBACK SYSTEM; MALE; MICRODIALYSIS; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SEROTONIN RELEASE;

AMYGDALA; ANIMALS; CITALOPRAM; FEEDBACK; INFUSIONS, PARENTERAL; KINETICS; MALE; MICRODIALYSIS; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SYNAPSES;

ANIMALIA;

EID: 0035109054     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00194.x     Document Type: Article

References (41)

1. 5-HT and antidepressants: New views from microdialysis studies
2. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
3. Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI)
4. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: A double-blind, placebo-controlled trial
5. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression
6. 1A agonist gepirone: Electrophysiological studies in the rat brain
7. Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression
8. 1A receptors without altering 5-HT autoreceptor sensitivity: An electrophysiological study in the rat brain
9. Systemic flesinoxan depresses hippocampal 5-HT release in the freely-moving guinea-pig
10. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin
11. 1A receptors
12. 1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: A microdialysis study with flesinoxan and Way 100635
13. 1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe
14. 1A receptors control 5-HT release in the rat medial prefrontal cortex
15. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex
16. 1B receptor antagonist depends on the dose of citalopram
17. Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram
18. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: A double-blind comparative study with fluvoxamine and maprotiline
19. 1A receptor antagonist
20. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis
21. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935
22. A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients
23. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study
24. 1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo
25. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis
26. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
27. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
28. Microdialysis measurement of in vivo neuropeptide release
29. 1A autoreceptors of the dorsal and median raphe nuclei
30. 1D in the rabbit and guinea-pig brain cortex
31. Dose response relationship of citalopram 20 mg, citalopram 40 mg, and placebo in the treatment of moderate and severe depression
32. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group
33. 1A antagonist WAY 100635 on 5-HT neuronal firing in the guinea pig dorsal raphé nucleus
34. Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection
35. o proteins in dorsal raphe nucleus
36. Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes
37. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis
38. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo
39. 1B agonists
40. Psychopharmacological treatment of social phobia; a double-blind placebo-controlled study with fluvoxamine